Enable JavaScript and then reload the page.
Metformin has a known GI effect that tends toward looser stools in some patients, which can partially offset GLP-1-related constipation
Studies of bariatric surgery consistently demonstrate bone density decreases following major weight loss, and similar patterns may occur with pharmacologically induced weight reduction
The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4
During drug shortages, theyre also authorized to craft medications that are essentially copies of commercially available drugs
Weight-loss outcomes vary based on your starting point, consistency, and overall health